EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSMOCG00000014822
Gene Symbol: PTGS2
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSMOCG00000001230
Gene Symbol: PSMA1
3 Cross references
254 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSMOCG00000013606
Gene Symbol: PSMA2
2 Cross references
234 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSMOCG00000011319
Gene Symbol: PSMA3
3 Cross references
229 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSMOCG00000001341
Gene Symbol: PSMA4
3 Cross references
241 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSMOCG00000022090
Gene Symbol: PSMA5
2 Cross references
208 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSMOCG00000002395
Gene Symbol: PSMA6
2 Cross references
247 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSMOCG00000000346
Gene Symbol: PSMA7
2 Cross references
149 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSMOCG00000016308
Gene Symbol: PSMA8
3 Cross references
197 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSMOCG00000010751
Gene Symbol: PSMB1
3 Cross references
216 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSMOCG00000009667
Gene Symbol: PSMB10
3 Cross references
171 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSMOCG00000003664
Gene Symbol: PSMB2
2 Cross references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).